Cargando…

An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19

SARS-CoV-2, the causative agent of COVID-19, claimed multiple lives in a very short span of time. Seeing the urgency of situation, vaccines were developed in hitherto unseen time frame. Vaccines definitely passed the test of safety and efficacy in clinical trials, but post mass vaccination data reve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muslim, Shahnawaz, Mustafa, Gulam, Nasrin, Nasrin, Firdaus, Aaisha, Singh, Shambhu Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903264/ https://www.ncbi.nlm.nih.gov/pubmed/36777902 http://dx.doi.org/10.1186/s43162-023-00191-7

Ejemplares similares

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

COVID-19 and Alcohol Poisoning: A Fatal Competition
por: Heidari, Mohammad, et al.
Publicado: (2021)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Postmortem investigation of fatalities following vaccination with COVID-19 vaccines
por: Schneider, Julia, et al.
Publicado: (2021)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

Covid-19 Vaccine safety and adverse event analysis from Pakistan
por: Hasan, Syed Shahzad, et al.
Publicado: (2022)

Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost?
por: Cirillo, Nicola, et al.
Publicado: (2022)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?
por: Nguyen, Kimberly H., et al.
Publicado: (2022)

Considerations in boosting COVID-19 vaccine immune responses
por: Krause, Philip R, et al.
Publicado: (2021)

Modeling waning and boosting of COVID-19 in Canada with vaccination
por: Childs, Lauren, et al.
Publicado: (2022)

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
por: Tan, C. Sabrina, et al.
Publicado: (2022)

Curcumin: Boosting the immunity of COVID-19-vaccinated populations
por: Widjaja, Sry Suryani, et al.
Publicado: (2022)

Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
por: Ajmera, Kunal M
Publicado: (2021)

Fatal neuromyelitis optica after COVID-19 vaccination
por: Boldrini, Vinícius de Oliveira, et al.
Publicado: (2022)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review
por: Keshavarz, Samaneh, et al.
Publicado: (2023)

Can existing unrelated vaccines boost a COVID-19 vaccine prime?
por: Hupert, Nathaniel, et al.
Publicado: (2021)

262 Safety and efficacy of the COVID-19 vaccine among fully vaccinated and boosted skin cancer patients
por: Raiker, R., et al.
Publicado: (2022)

COVID-19 Vaccination in Pregnancy: Factors influencing uptake by women
por: Javid, Nasrin, et al.
Publicado: (2022)

Predictors of Pediatric COVID-19 vaccination: a case-control study in Tabriz, Iran
por: Sarbakhsh, Parvin, et al.
Publicado: (2023)

Pregnancy safety of COVID-19 vaccines is validated by the Vaccine Adverse Event Reporting System
por: Grunebaum, Amos, et al.
Publicado: (2022)

Cardiac Adverse Reactions With COVID-19 Vaccinations
por: De Jesus, Mikhail L, et al.
Publicado: (2022)

Signaling COVID-19 Vaccine Adverse Events
por: Harpaz, Rave, et al.
Publicado: (2022)

Adverse Events After COVID-19 Vaccination
Publicado: (2022)

Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
por: Makadzange, Azure Tariro, et al.
Publicado: (2022)

COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Zhang, Bing, et al.
Publicado: (2022)

Analyzing the public sentiment on COVID-19 vaccination in social media: Bangladesh context
por: Zulfiker, Md. Sabab, et al.
Publicado: (2022)

Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination
por: Beatty, Alexis L., et al.
Publicado: (2021)

Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
por: Roncati, Luca, et al.
Publicado: (2020)

Emphasize personal health benefits to boost COVID-19 vaccination rates
por: Ashworth, Madison, et al.
Publicado: (2021)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
por: Shaw, Robert H, et al.
Publicado: (2021)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
por: Choudhary, Om Prakash, et al.
Publicado: (2021)

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
por: Garg, Ishan, et al.
Publicado: (2022)

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
por: Ripoll, Juan G., et al.
Publicado: (2022)

One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database
por: DeVries, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fr9f1ujnkops9b388drlo8hquj